Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index; 21 of the 83 sources its claims cite were checked for support.
Abstract
Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated with a sedentary lifestyle, adipose tissue derangements, comorbidities (acute and chronic diseases) and during the ageing process. Co-existence of excess adiposity and low muscle mass/function is referred to as sarcopenic obesity (SO), a condition increasingly recognized for its clinical and functional features that negatively influence important patient-centred outcomes. Effective prevention and treatment strategies for SO are urgently needed, but efforts are hampered by the lack of a universally established SO definition and diagnostic criteria. Resulting inconsistencies in the literature also negatively affect the ability to define prevalence as well as clinical relevance of SO for negative health outcomes. Aims and Methods: The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) launched an initiative to reach expert consensus on a definition and diagnostic criteria for SO. The jointly appointed international expert panel proposes that SO is defined as the co-existence of excess adiposity and low muscle mass/function. The diagnosis of SO should be considered in at-risk individuals who screen positive for a co-occurring elevated body mass index or waist circumference, and markers of low skeletal muscle mass and function (risk factors, clinical symptoms, or validated questionnaires). Diagnostic procedures should initially include assessment of skeletal muscle function, followed by assessment of body composition where presence of excess adiposity and low skeletal muscle mass or related body compartments confirm the diagnosis of SO. Individuals with SO should be further stratified into stage I in the absence of clinical complications or stage II if cases are associated with complications linked to altered body composition or skeletal muscle dysfunction. Conclusions: ESPEN and EASO, as well as the expert international panel, advocate that the proposed SO definition and diagnostic criteria be implemented into routine clinical practice. The panel also encourages prospective studies in addition to secondary analysis of existing data sets, to study the predictive value, treatment efficacy and clinical impact of this SO definition.
Overview
CoChat Summary
TL;DR
This ESPEN/EASO consensus statement defines sarcopenic obesity (SO) as the co-existence of excess adiposity and low muscle mass/function and proposes a screening, diagnosis, and staging algorithm. After a four-phase Delphi process, the expert panel reached 93.6% agreement on the global proposal.
Key findings
- SO is defined as the co-existence of obesity and sarcopenia: obesity as high body fat percentage, and sarcopenia as low skeletal muscle mass accompanied by low muscle function. Diagnosis requires both altered skeletal muscle functional parameters and altered body composition after positive screening.
- Screening uses elevated BMI or waist circumference with ethnicity-specific cut points plus surrogate indicators/risk factors or validated questionnaires (e.g., SARC-F in older subjects); all people with obesity/overweight above age 70 are considered at risk of SO.
- Diagnostic sequence: assess skeletal muscle function first (e.g., hand-grip strength, knee extensor strength, chair-stand test), then body composition by DXA or BIA as second choice, with CT when possible. The panel suggests cut points from Dodds et al. and Chen et al. for HGS, Gallagher et al. for FM, Janssen et al. for SMM/W, and Batsis et al. for ALM/W. Staging is Stage I (no complications) or Stage II (at least one complication attributable to altered body composition and skeletal muscle functional parameters).
- The background systematic review found unified fat-plus-muscle parameters in only 6 of 75 selected studies; 28 of 75 studies had a mean age below 65 years. In a sample of 727 participants with obesity, SO prevalence was 34.8% in males and 50.1% in females; in another sample of 147 individuals with obesity, 63.3% met criteria for reduced lean mass. Proposed upper sex-specific body fat cut-offs were 40% for females and 30% for males.
Methods
- ESPEN and EASO launched a consensus initiative following standard operating procedures for ESPEN guidelines and consensus papers. A pool of 38 international researchers from 16 countries on four continents contributed, with five members coordinating.
- The consensus procedure used a four-phase Delphi process with sequential web-based questionnaires (rounds in 2020–2021). Participants ranked statements on a 5-point Likert scale, and statements with >75% positive responses (agree or strongly agree) advanced.
- After four rounds, the global proposal encompassing SO definition, screening, diagnosis, and staging reached 93.6% agreement (agree + strongly agree).
Limitations
- Stated: the statements are expert-based rather than necessarily evidence-based; the group was self-appointed, initiated by ESPEN and EASO representatives with subsequent expert panel selection. Lack of consistency in prior operational criteria may affect any consensus initiative.
- Stated: the staging proposal has not been investigated and is based entirely on clinical expert opinion. No universally accepted validated references are available for most parameters; it remains unclear whether T scores or Z scores should be used, and cut-offs need validation against specific adverse outcomes.
- Evident from the text: the proposed algorithm and staging are not empirically tested in this paper, and many cited cut-offs come from heterogeneous populations by age, sex, and ethnicity, with most studies in Caucasian groups, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 3 Not valid · 34 Not checked · 37 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, near-normal skeletal muscle mass according to reference ranges for the general non-obese population may be accompanied by lower or inadequate muscle strength and performance in individuals with obesity [82].”
What the sources say
- Partly supportedcites [82] matched to “Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through e IF 2α activation” (2014) sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports that muscle fat accumulation in older people is associated with reduced strength and poorer performance-test scores. It does not establish that people with obesity can have near-normal muscle mass by non-obese reference ranges while having inadequate strength or performance; the paper’s own experiments concern old rats. (LLM, conf=0.82)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Individuals with obesity may conversely have comparable or even higher absolute skeletal muscle mass relative to nonobese counterparts, due to higher overall body mass and potentially higher related muscle workload in daily physical activity [80, 81].”
What the sources say
- Could not verifycites [80] matched to “Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention” (2014) sourceExperimental — accuracy not yet measured
The section “The Value of Assessing LST: Clinical Considerations” discusses muscle loss occurring alongside obesity, but does not compare absolute skeletal muscle mass in obese and nonobese people. Searches for that comparison and for increased muscle workload from higher body mass found no passage addressing either point. (LLM, conf=0.73)
- Partly supportedcites [81] matched to “Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging” (2020) sourceExperimental — accuracy not yet measured
The Calorie Restriction section (page unavailable) reports that obese adults had larger muscle-fiber cross-sectional area, which lends limited support to the comparison with nonobese adults. It does not establish that they have comparable or higher absolute skeletal muscle mass, or attribute any difference to body mass or greater muscle workload during daily activity. (LLM, conf=0.78)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In 28 of the 75 studies selected in our recent SO systematic review [20], the mean age of the studied population was below 65 years.”
What the sources say
- Partly supportedcites [20] matched to “Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review” (2020) sourceExperimental — accuracy not yet measured
The 'Study characteristics' section (p. 1 of our copy) confirms the denominator and the age theme: 75 articles were selected and 'the mean age of the participants was 64.8±4.5 years (range: 20-92)', and 'Search results' confirms the 75 included studies. However, nowhere in our copy is the specific count '28 studies with a mean age below 65 years' stated; Table 1 lists per-study ages (e.g. An KO 58.7, Baek J 43.55, Kim YS 31.0/30.8, Srikanthan 45.0) from which such a figure could be derived, but the paper itself reports only the pooled mean age, not a tally of studies above/below 65. So the 75-study part is supported and the '28' figure is not attributable to this source as printed. (LLM, conf=0.68)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, the unified parameters differed in the respective studies [20].”
What the sources say
- Supportedcites [20] matched to “Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review” (2020) source
The DISCUSSION section states that 'only a minority of studies selected in the present systematic review have employed unified parameters with both fat and muscle measurements related in a single criterion', and then lists the differing examples used by different studies (visceral FM/ASMI ratio in Siervo et al., visceral adipose tissue/thigh muscle ratios from CT in K-NHANES and East Asian cohorts). The 'Definitions of sarcopenic obesity' section corroborates this heterogeneity: 3 studies used residuals of linear regression predicting AFFM, while 2 studies used FM/FFM or visceral adipose tissue area to thigh muscle area ratios [41,70]. Together these passages support that the unified parameters differed across the reviewed studies. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“while recognizing the important limitations of BMI in the detection of fat distribution and body composition [24, 25, 93].”
What the sources say
- Supportedcites [24] matched to “Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004” (2016) source
The Discussion (page not provided) states that BMI suboptimally identifies adiposity when compared with DEXA body-composition measures. It also notes differences associated with central obesity in people misclassified by BMI, supporting the stated limitation concerning fat distribution. (LLM, conf=0.90)
- Partly supportedcites [25] matched to “New Criteria for `Obesity Disease' in Japan” (2002) sourceExperimental — accuracy not yet measured
In “Assessing Visceral Fat Accumulation by CT Scanning” (page unavailable), BMI correlated weakly with visceral fat area, supporting a limitation in detecting fat distribution. The paper does not separately establish the claimed limitation in detecting body composition. (LLM, conf=0.86)
- Partly supportedcites [93] matched to “Cut‐offs for calf circumference as a screening tool for low muscle mass: WASEDA'S Health Study” (2020) sourceExperimental — accuracy not yet measured
The Methods (Muscle mass measurements; page not available) use DXA, rather than BMI, to measure body fat percentage and lean tissue mass; the Results also define obesity by DXA-measured body fat percentage. This is consistent with a limitation of BMI for assessing body composition, but the paper does not discuss BMI's ability to detect fat distribution or explicitly characterize its limitations as important. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
37 more claims · 2 with their cited sources checked
Create a free account to see all 85 claims and to verify the 62 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More potent agents such as tirzepatide and high-dose semaglutide induce substantial weight loss (~ 15–24%) and reduce both fat and lean mass.”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenia definitions have evolved through European and Asian consensus updates that place greater emphasis on muscle strength and physical performance, while the ESPEN and EASO consensus and the Sarcopenic Obesity Global Leadership Initiative have attempted to standardize SO diagnosis and research priorities (2, 7–9).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Differential changes in the phenotypic criteria of SO have been generally gone undetected in terms of their impact on adverse health outcomes [1, 2, 3].”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenesis of SO, while not fully elucidated, involves elevated adipose deposits leading to the expression of antimyogenic adipokines and pro‐inflammatory responses that accelerate muscle function and/or mass loss.”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This promotes metabolic complications and inhibits the anabolic actions of insulin‐like growth factor IGF‐1, which have an effect on the musculoskeletal system [1, 21].”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [1]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Self-citation(2000) · PubMed · Cited by 13,173
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Self-citationSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Self-citationJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Self-citation
Research works printed but not linked: 1
- 10.1007/s10522-015-9626-484 · doi:10.1007/s10522-015-9626-484
Cited by
Sarcopenia and Cardiovascular Diseases
Damluji, A. A., Alfaraidhy, M., AlHajri, N., Rohant, N. N., Kumar, M., Al Malouf, C., Bahrainy, S., Ji Kwak, M., Batchelor, W. B., Forman, D. E., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064071 · Cited by 645
A new framework for the diagnosis, staging and management of obesity in adults
Busetto, L., Dicker, D., Frühbeck, G., Halford, J. C. G., Sbraccia, P., Yumuk, V., & Goossens, G. H. (2024) · Nature Medicine · doi:10.1038/s41591-024-03095-3 · Cited by 501
Self-citationChanges in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies
Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15728 · Cited by 391
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“Consequently, the concept of ‘relative adequate muscle’ has been proposed for the clinical identification of sarcopenic obesity 2,3 , but additional research is needed.”
InfluentialSelf-citationChen, L.-K., Hsiao, F.-Y., Akishita, M., Assantachai, P., Lee, W.-J., Lim, W. S., Muangpaisan, W., Kim, M., Merchant, R. A., Peng, L.-N., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01004-y · Cited by 262
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People
Benz, E., Pinel, A., Guillet, C., Capel, F., Pereira, B., De Antonio, M., Pouget, M., Cruz-Jentoft, A. J., Eglseer, D., Topinkova, E., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3604 · Cited by 261
Self-citationDuarte, M. P., Almeida, L. S., Neri, S. G. R., Oliveira, J. S., Wilkinson, T. J., Ribeiro, H. S., & Lima, R. M. (2024) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13425 · Cited by 243
Sarcopenic obesity: Emerging mechanisms and therapeutic potential
Axelrod, C. L., Dantas, W. S., & Kirwan, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155639 · Cited by 204
Piccoli, G. B., Cederholm, T., Avesani, C. M., Bakker, S. J. L., Bellizzi, V., Cuerda, C., Cupisti, A., Sabatino, A., Schneider, S., Torreggiani, M., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.01.018 · Cited by 146
Self-citationLinge, J., Birkenfeld, A. L., & Neeland, I. J. (2024) · Circulation · doi:10.1161/circulationaha.124.067676 · Cited by 180
Obesity Paradox: Fact or Fiction?
Simati, S., Kokkinos, A., Dalamaga, M., & Argyrakopoulou, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00497-1 · Cited by 169
ESPEN guideline on clinical nutrition in surgery – Update 2025
Weimann, A., Bezmarevic, M., Braga, M., Correia, M. I. T. D., Funk-Debleds, P., Gianotti, L., Gillis, C., Hübner, M., Inciong, J. F. B., Jahit, M. S., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.08.029 · Cited by 167
Self-citationBajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s008 · Cited by 165
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Obesity and sleep disorders: A bidirectional relationship
Figorilli, M., Velluzzi, F., & Redolfi, S. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104014 · Cited by 144
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
Preda, A., Carbone, F., Tirandi, A., Montecucco, F., & Liberale, L. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09813-5 · Cited by 142
The role of diet and nutrition in the management of COPD
Beijers, R. J. H. C. G., STEINER, M. C., & Schols, A. M. W. J. (2023) · European Respiratory Review · doi:10.1183/16000617.0003-2023 · Cited by 127
Kotlyarov, S. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108725 · Cited by 122
Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?
Tarantino, G., Sinatti, G., Citro, V., Santini, S. J., & Balsano, C. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03339-z · Cited by 116
Gortan Cappellari, G., Guillet, C., Poggiogalle, E., Ballesteros Pomar, M. D., Batsis, J. A., Boirie, Y., Breton, I., Frara, S., Genton, L., Gepner, Y., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.02.018 · Cited by 113
Self-citationGLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway
Xiang, J., Qin, L., Zhong, J., Xia, N., & Liang, Y. (2023) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s425642 · Cited by 100
Physical activity and exercise for weight loss and maintenance in people living with obesity
Oppert, J.-M., Ciangura, C., & Bellicha, A. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09805-5 · Cited by 99
Cruz-Jentoft, A. J., Gonzalez, M. C., & Prado, C. M. (2023) · European Geriatric Medicine · doi:10.1007/s41999-023-00760-7 · Cited by 83
Self-citationAvesani, C. M., de Abreu, A. M., Ribeiro, H. S., Brismar, T. B., Stenvinkel, P., Sabatino, A., & Lindholm, B. (2023) · Journal of Nephrology · doi:10.1007/s40620-022-01553-0 · Cited by 83
Hou, Y., Xiang, J., Wang, B., Duan, S., Song, R., Zhou, W., Tan, S., & He, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263650 · Cited by 82
Liu, X., Chen, X., & Cui, J. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.06.007 · Cited by 78
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.003 · Cited by 59
Self-citationSarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome
Mirzai, S., Carbone, S., Batsis, J. A., Kritchevsky, S. B., Kitzman, D. W., & Shapiro, M. D. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00571-2 · Cited by 76
Self-citationMalandrino, N., Bhat, S. Z., Alfaraidhy, M., Grewal, R. S., & Kalyani, R. R. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.001 · Cited by 75
Heavy arch: from inflammatory bowel diseases to metabolic disorders
Adolph, T. E., Meyer, M., Jukic, A., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2024-331914 · Cited by 74
Zhang, X., Ding, L., Hu, H., He, H., Xiong, Z., & Zhu, X. (2023) · The journal of nutrition health & aging · doi:10.1007/s12603-023-2001-2 · Cited by 74
The prevalence of low muscle mass associated with obesity in the USA
Murdock, D. J., Wu, N., Grimsby, J. S., Calle, R. A., Donahue, S., Glass, D. J., Sleeman, M. W., & Sanchez, R. J. (2022) · Skeletal Muscle · doi:10.1186/s13395-022-00309-5 · Cited by 73
Orsso, C. E., Montes‐Ibarra, M., Findlay, M., van der Meij, B. S., de van der Schueren, M. A. E., Landi, F., Laviano, A., & Prado, C. M. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12954 · Cited by 73
Self-citationAgius, R., Pace, N. P., & Fava, S. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3725 · Cited by 74
Sarcopenic obesity and weight loss-induced muscle mass loss
Caturano, A., Amaro, A., Berra, C., & Conte, C. (2025) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001131 · Cited by 73
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12280 · Cited by 71
Self-citationDiabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes: Expert document
de Luis, D. A., Carretero‐Gómez, J., García‐Almeida, J. M., Vallo, F. G., Rolo, G. G., Gómez, J. J. L., Tarazona‐Santabalbina, F. J., & Sanz‐París, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09871-9 · Cited by 69
Acute Sarcopenia: Mechanisms and Management
Damanti, S., Senini, E., LORENZO, R. D., Merolla, A., Santoro, S., Festorazzi, C., Messina, M., Vitali, G., Sciorati, C., & Rovere, P. Q. (2024) · Nutrients · doi:10.3390/nu16203428 · Cited by 60
Sarcopenic obesity and health outcomes: An umbrella review of systematic reviews with meta‐analysis
Veronese, N., Ragusa, F. S., Pegreffi, F., Dominguez, L. J., Barbagallo, M., Zanetti, M., & Cereda, E. (2024) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13502 · Cited by 56
Towards an adiposity-related disease framework for the diagnosis and management of obesities
Perdomo, C. M., Avilés-Olmos, I., Dicker, D., & Frühbeck, G. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09797-2 · Cited by 56
Self-citationGengxin, Y., Xuehan, M., Xinyu, W., Yali, Y., Yiran, X., Zheng, L., Qiu, Y., Li, G., & Chen, L. (2025) · Age and Ageing · doi:10.1093/ageing/afae286 · Cited by 56
Savarese, G., Schiattarella, G. G., Lindberg, F., Anker, M. S., Bayés‐Genís, A., Bäck, M., Braunschweig, F., Bucciarelli‐Ducci, C., Butler, J., Cannata, A. N., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3676 · Cited by 57
Sievenpiper, J. L., Ard, J. D., Blüher, M., Chen, W., Dixon, J. B., Fitch, A., Gigliotti, L., Khunti, K., Lecube, A., Lean, M., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100228 · Cited by 56
Malnutrition risk screening: New insights in a new era
de van der Schueren, M. A. E., & Jager-Wittenaar, H. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.08.007 · Cited by 55
Vendrell, C. S., Tercero, E. G., Hernández, J. B. M., & Cedeño‐Veloz, B. A. (2023) · Nutrients · doi:10.3390/nu15194149 · Cited by 55
Özkök, S., Aydın, Ç. Ö., Sacar, D. E., Çatıkkaş, N. M., Erdoğan, T., Bozkurt, M. E., Kılıç, C., Karan, M. A., & Bahat, G. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.09.005 · Cited by 55
Bone health in adults with obesity before and after interventions to promote weight loss
Paccou, J., & Compston, J. E. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00163-3 · Cited by 54
GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review
Pantazopoulos, D., Gouveri, E., Papazoglou, D., & Παπάνας, Ν. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112924 · Cited by 53
Hwang, J., & Park, S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021140 · Cited by 52
Brown, L. R., Sousa, M. S., Yule, M. S., Baracos, V. E., McMillan, D. C., Arends, J., Balstad, T. R., Bye, A., Dajani, O. F., Dolan, R. D., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13478 · Cited by 52
Zamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 51
Self-citationThe paradox of obesity with normal weight; a cross-sectional study
Lahav, Y., Kfir, A., & Gepner, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1173488 · Cited by 51
Self-citationBischoff, S. C., Ockenga, J., Eshraghian, A., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Kani, H. T., Khannoussi, W., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.021 · Cited by 49
Self-citationSoto, M. E., Pérez-Torres, I., Rubio-Ruiz, M. E., Cano-Martínez, A., Manzano-Pech, L., & Guarner‐Lans, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054534 · Cited by 49
Poor muscle quality: A hidden and detrimental health condition in obesity
Vieira, F. T., Cai, Y., González, M. C., Goodpaster, B. H., Prado, C. M. M., & Haqq, A. M. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09941-0 · Cited by 48
Self-citationRen, Y., Wang, K., Wu, Y., Li, J., Ma, J., Wang, L., Zhang, C., Li, J., Wei, Y., & Yang, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140488 · Cited by 48
Semenova, E. A., Pranckevičienė, E., Bondareva, E. A., Gabdrakhmanova, L. J., & Ahmetov, I. I. (2023) · Nutrients · doi:10.3390/nu15030758 · Cited by 47
Schluessel, S., Huemer, M.-T., Peters, A., Drey, M., & Thorand, B. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.08.002 · Cited by 46
The Asia–Oceania consensus: Definitions and diagnostic criteria for sarcopenic obesity
Chen, T., Kao, H., Ogawa, W., Arai, H., Tahapary, D. L., Assantachai, P., Tham, K. W., Chan, D., Yuen, M. M. A., Appannah, G., et al. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.05.001 · Cited by 47
Murawiak, M., Krzymińska-Siemaszko, R., Kaluźniak-Szymanowska, A., Lewandowicz, M., Tobis, S., Wieczorowska-Tobis, K., & Deskur-Śmielecka, E. (2022) · Nutrients · doi:10.3390/nu14142889 · Cited by 37
Szczerbiński, Ł., & Florez, J. C. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00232-2 · Cited by 45
Sedentary lifestyle and physical inactivity: A mutual interplay with early and overt frailty
Battista, F., Duregon, F., Vecchiato, M., Ermolao, A., & Neunhäeuserer, D. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103971 · Cited by 45
Phase angle is associated with sarcopenic obesity in post-stroke patients
Yoshimura, Y., Wakabayashi, H., Nagano, F., Matsumoto, A., Shimazu, S., Shiraishi, A., Kido, Y., Bise, T., Hori, K., & Yoneda, K. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.018 · Cited by 45
Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery
Vieira, F. T., Godziuk, K., Lamarca, F., Melendez-Araújo, M. S., Lima, R. M., Prado, C. M., de Carvalho, K. M. B., & Dutra, E. S. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.006 · Cited by 38
Self-citationZhou, Y., Wang, J., Yao, Q., Jian, Q.-F., & Luo, Z.-P. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.09.920 · Cited by 45
Zhou, H., Su, H., Gong, Y., Chen, L., Xu, L., Chen, G., & Tong, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-61928-0 · Cited by 45
Yu, B., Jia, S., Sun, T., Liu, J., Jin, J., Zhang, S., Xiao, Q., Dong, H., & Ou, Y. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100353 · Cited by 45
Zembura, M., Czepczor‐Bernat, K., Dolibog, P., Dolibog, P., & Matusik, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1252853 · Cited by 43
Booranasuksakul, U., Macdonald, I. A., Stephan, B. C. M., & Siervo, M. (2024) · Journal of the American Nutrition Association · doi:10.1080/27697061.2024.2333310 · Cited by 43
Self-citationFemale obesity: clinical and psychological assessment toward the best treatment
Guglielmi, V., Grave, R. D., Leonetti, F., & Solini, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1349794 · Cited by 44
Liang, Y., Kaushal, D., & Wilson, R. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147943 · Cited by 44
Sabatino, A., Avesani, C. M., Regolisti, G., Adinolfi, M., Benigno, G. D., Delsante, M., Fiaccadori, E., & Gandolfini, I. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.032 · Cited by 42
Teixeira, L. A. D. C., Soares, L. A., da Fonseca, S. F., Gonçalves, G. T., dos Santos, J. M., Viegas, Â. A., Parentoni, A. N., Figueiredo, P. H. S., Mendonça, V. A., & Lacerda, A. C. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-76417-7 · Cited by 42
Prokopidis, K., Daly, R. M., & Suetta, C. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2025.100652 · Cited by 40
“Sarcopenic obesity is a condition characterized by the simultaneous presence of excessive adiposity and low muscle mass and/or function [6] that is estimated to affect 10 – 20 % of older adults, depending on the diagnostic criteria [7].”
Araújo, L. P., Godoy, A. C. F., Frota, F. F., Lamas, C. B., Quesada, K. R., Detregiachi, C. R. P., Araújo, A. C., Miglino, M. A., Guiguer, É. L., Haber, R. S. D. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412147 · Cited by 40
Musculoskeletal effects of obesity and bariatric surgery – a narrative review
de Holanda, N. C. P., Crispim, N., Carlos, I. D. L., Moura, T., Nóbrega, E., & Bandeira, F. A. F. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000551 · Cited by 40
Precision nutrition in the context of bariatric surgery
Aguas‐Ayesa, M., Yárnoz‐Esquíroz, P., Olazarán, L., Gómez‐Ambrosi, J., & Frühbeck, G. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09794-5 · Cited by 39
Self-citationLiang, Z., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1733798 · Cited by 39
2026 ESC Guidelines on cardiac rehabilitation
Bäck, M., Wilhelm, M., Marcin, T., Machado, F. V. C., Sandberg, A., Buccheri, S., Conde, A. C., Czapla, M., Rosa, S. D., Gibson, I., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag099 · Cited by 41
Multimodal Diagnostic Approaches to Advance Precision Medicine in Sarcopenia and Frailty
Lynch, D. H., Spangler, H., Franz, J. R., Krupenevich, R. L., Kim, H., Nissman, D., Zhang, J., Li, Y., Sumner, S., & Batsis, J. A. (2022) · Nutrients · doi:10.3390/nu14071384 · Cited by 38
Self-citationDefining and diagnosing sarcopenia: Is the glass now half full?
Barazzoni, R., Cederholm, T., Zanetti, M., & Cappellari, G. G. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155558 · Cited by 38
Self-citationChao, C., Kovesdy, C. P., & Merchant, R. A. (2025) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.24.207 · Cited by 37
Sun, L., Fu, J., Mu, Z., Duan, X., Chan, P., & Xiu, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1094075 · Cited by 37
Vieira, F. T., de Oliveira, G. S., Gonçalves, V. S. S., Neri, S. G. R., de Carvalho, K. M. B., & Dutra, E. S. (2022) · PLOS ONE · doi:10.1371/journal.pone.0269699 · Cited by 36
Uncovering sarcopenia and frailty in older adults by using muscle ultrasound—A narrative review
Prell, T., Grimm, A. M., & Axer, H. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1333205 · Cited by 36
Reiter, L., Bauer, S., Traxler, M., Schoufour, J. D., Weijs, P. J. M., Cruz-Jentoft, A., Topinková, E., & Eglseer, D. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00509-0 · Cited by 35
Self-citationBuso, G., Favre, L., Vionnet, N., Rodríguez, E. G., Hans, D. B., Puder, J. J., Dubath, C., Eap, C. B., Raffoul, W., Collet, T., et al. (2022) · Obesity Facts · doi:10.1159/000527138 · Cited by 35
Zou, Y., Ye, H., Xu, Z., Yang, Q., Zhu, J., Li, T., Cheng, Y., Zhu, Y., Zhang, J., Bo, Y., et al. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae284 · Cited by 35
Prado, C. M. M., Gonzalez, M. C., Norman, K., Orsso, C. E., Barazzoni, R., Cederholm, T., Compher, C. W., Jensen, G. L., Abe, T., Barbosa-Silva, T. G., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101283 · Cited by 38
Self-citationStress and cardiovascular risk burden after the pandemic: current status and future prospects
Mattioli, A. V., Coppi, F., Nasi, M., & Gallina, S. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2092097 · Cited by 35
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Papadopetraki, A., Giannopoulos, A., Maridaki, M., Zagouri, F., Droufakou, S., Koutsilieris, M., & Philippou, A. (2023) · Cancers · doi:10.3390/cancers15245856 · Cited by 34
“…overcome incomplete and possibly ineffective diagnosis of SO, the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) recently published a consensus statement for the definition of SO and its uniform diagnostic criteria [56].”
BackgroundGórnicka, M., Szewczyk, K., Bialkowska, A. B., Jančichová, K., Habánová, M., Górnicki, K., & Hamułka, J. (2022) · Applied Sciences · doi:10.3390/app12126165 · Cited by 34
Trinkner, P., Günther, S., Monsef, I., Kerschbaum, E., von Bergwelt‐Baildon, M., dos Santos, D. M. C., & Theurich, S. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.01.030 · Cited by 33
Gonçalves, L. D. S., da Silva, L. S. L., Benjamim, C. J. R., Júnior, M. F. T., Bohn, L., Abud, G. F., Ortiz, G. U., & de Freitas, E. C. (2023) · The journal of nutrition health & aging · doi:10.1007/s12603-023-2018-6 · Cited by 34
Vincenzo, O. D., Minnetti, M., Baker, J. L., Barazzoni, R., Boyland, E. J., Busetto, L., Ciudin, A., Dicker, D., Fábryová, Ľ., Helgason, T., et al. (2025) · Obesity Facts · doi:10.1159/000549751 · Cited by 33
Self-citationSarcopenic obesity: epidemiology, pathogenesis and diagnostic criteria
Berns, S. A., Sheptulina, A. F., Mamutova, E. M., Kiselev, A. R., & Drapkina, O. M. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3576 · Cited by 31
The association of testosterone with sarcopenia and frailty in chronic liver disease
Chrysavgis, L., Adamantou, M., Angelousi, A. G., & Cholongitas, Ε. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14108 · Cited by 31
Scheen, A. J. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101681 · Cited by 30
Sarcopenia in interstitial lung disease
Sheehy, R. D., McCormack, S. R., Fermoyle, C. C., & Corte, T. J. (2024) · European Respiratory Review · doi:10.1183/16000617.0126-2024 · Cited by 30
Sılay, K., & Öztorun, H. S. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06105-2 · Cited by 30
Metadata
- Authors
- Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., Frara, S., Frühbeck, G., Genton, L., Gepner, Y., Giustina, A., Gonzalez, M. C., Han, H.-S., Heymsfield, S. B., Higashiguchi, T., Laviano, A., Lenzi, A., Nyulasi, I., Parrinello, E., Poggiogalle, E., Prado, C. M., Salvador, J., Rolland, Y., Santini, F., Serlie, M. J., Shi, H., Sieber, C. C., Siervo, M., Vettor, R., Villareal, D. T., Volkert, D., Yu, J., Zamboni, M., & Barazzoni, R.
- Affiliations
- Sapienza University of Rome (IT)
- University of Padua (IT)
- University of Hohenheim (DE)
- Uppsala University (SE)
- University of North Carolina at Chapel Hill (US)
- Heidelberg University (DE)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Tel Aviv University (IL)
- Vita-Salute San Raffaele University (IT)
- Clinica Universidad de Navarra (ES)
- University Hospital of Geneva (CH)
- Seoul National University Bundang Hospital (KR)
- Pennington Biomedical Research Center (US)
- Fujita Health University (JP)
- Monash University (AU)
- University of Alberta (CA)
- Universidad de Navarra (ES)
- Inserm (FR)
- University of Pisa (IT)
- Amsterdam University Medical Centers (NL)
- Capital Medical University (CN)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Nottingham (GB)
- Baylor College of Medicine (US)
- Peking Union Medical College Hospital (CN)
- University of Verona (IT)
- University of Trieste (IT)
- ORCID
- Donini, Lorenzo M.
- Busetto, Luca
- Bischoff, Stephan C.
- Cederholm, Tommy
- Ballesteros-Pomar, Maria D.
- Batsis, John A.
- Boirie, Yves
- Cruz-Jentoft, Alfonso J.
- Dicker, Dror
- Frara, Stefano
- Frühbeck, Gema
- Genton, Laurence
- Gepner, Yftach
- Gonzalez, Maria Cristina
- Han, Ho-Seong
- Heymsfield, Steven B.
- Laviano, Alessandro
- Lenzi, Andrea
- Nyulasi, Ibolya
- Parrinello, Edda
- Poggiogalle, Eleonora
- Prado, Carla M.
- Salvador, Javier
- Rolland, Yves
- Santini, Ferruccio
- Serlie, Mireille J.
- Shi, Hanping
- Sieber, Cornel C.
- Siervo, Mario
- Vettor, Roberto
- Villareal, Dennis T.
- Volkert, Dorothee
- Yu, Jianchun
- Zamboni, Mauro
- Barazzoni, Rocco
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 15
- Issue
- 3
- Pages
- 321-335
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC9210010
- OpenAlex
- W4225632118
- Cited by
- 1,019
- References
- 126
- Citations by year
- 2026: 287 · 2025: 281 · 2024: 246 · 2023: 156 · 2022: 49
- FWCI
- 113.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- HAL (submittedVersion, cc-by-nc)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056350)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- sarcopenic obesity, sarcopenia, obesity, diagnostic criteria, definitions, skeletal muscle mass, skeletal muscle function, body composition, excess adiposity, body mass index, waist circumference, disease staging
- MeSH terms
- Body Composition, Humans, Obesity, Prospective Studies, Body Mass Index, Muscle, Skeletal, Adiposity, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.